42-(2-Tetrazolyl)rapamycin

42-(2-Tetrazolyl)rapamycin

• CAS Number: 221877-56-1
• UNSPSC Description: 42-(2-Tetrazolyl)rapamycin is a proagent compound of a rapamycin analog extracted from patent US 20080171763 A1, Example 1. Rapamycin is a specific mTOR inhibitor.
• Target Antigen: Others
• Type: Reference compound
• Related Pathways: Others
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/42-_2-Tetrazolyl_rapamycin.html
• Purity: 98.65
• Solubility: DMSO : ≥ 130 mg/mL
• Smiles: [H][C@]1(C(O[C@@]([C@@H](C[C@H]2C[C@@H](OC)[C@@H](N3N=CN=N3)CC2)C)([H])CC([C@@H](/C=C([C@@H](O)[C@H]4OC)\C)C)=O)=O)N(C(C([C@@]5(O)[C@H](C)CC[C@](C[C@@H](/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C4=O)OC)([H])O5)=O)=O)CCCC1
• Molecular Weight: 966.21
• References & Citations: [1]Karl W. Mollison, et al. Compounds and methods for treatment and prevention of diseases. US 20080171763 A1.|[2]Ballou LM, et al. Rapamycin and mTOR kinase inhibitors. J Chem Biol. 2008 Nov;1(1-4):27-36.
• Shipping Conditions: Blue Ice
• Storage Conditions: -20°C, 3 years (Powder)
• Clinical Information: No Development Reported